Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway.
Breast cancer screening
EQ-5D-5L
Interval breast cancer
Quality of life
Symptomatic breast cancer
Journal
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
accepted:
06
10
2021
pubmed:
27
10
2021
medline:
31
3
2022
entrez:
26
10
2021
Statut:
ppublish
Résumé
Breast cancers detected at screening need less aggressive treatment compared to breast cancers detected due to symptoms. The evidence on the quality of life associated with screen-detected versus symptomatic breast cancer is sparse. This study aimed to compare quality of life among Norwegian women with symptomatic, screen-detected and interval breast cancer, and women without breast cancer and investigate quality adjusted life years (QALYs) for women with breast cancer from the third to 14th year since diagnosis. This retrospective cross-sectional study was focused on women aged 50 and older. A self-reported questionnaire including EQ-5D-5L was sent to 11,500 women. Multivariable median regression was used to analyze the association between quality of life score (visual analogue scale 0-100) and detection mode. Health utility values representing women's health status were extracted from EQ-5D-5L. QALYs were estimated by summing up the health utility values for women stratified by detection mode for each year between the third and the 14th year since breast cancer diagnosis, assuming that all women would survive. Adjusted regression analyses showed that women with screen-detected (n = 1206), interval cancer (n = 1005) and those without breast cancer (n = 1255) reported a higher median quality of life score using women with symptomatic cancer (n = 1021) as reference; 3.7 (95%CI 2.2-5.2), 2.3 (95%CI 0.7-3.8) and 4.8 (95%CI 3.3-6.4), respectively. Women with symptomatic, screen-detected and interval cancer would experience 9.5, 9.6 and 9.5 QALYs, respectively, between the third and the 14th year since diagnosis. Women with screen-detected or interval breast cancer reported better quality of life compared to women with symptomatic cancer. The findings add benefits of organized mammographic screening.
Identifiants
pubmed: 34698976
doi: 10.1007/s11136-021-03017-7
pii: 10.1007/s11136-021-03017-7
pmc: PMC8547129
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1057-1068Subventions
Organisme : Stiftelsen Dam
ID : N 2019/FO244363
Informations de copyright
© 2021. The Author(s).
Références
DeSantis, C. E., Bray, F., Ferlay, J., Lortet-Tieulent, J., Anderson, B. O., & Jemal, A. (2015). International variation in female breast cancer incidence and mortality rates. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 24(10), 1495–1506.
doi: 10.1158/1055-9965.EPI-15-0535
Cancer Registry of Norway. (2020). Cancer in Norway 2019—Cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway.
Sebuødegård, S., Botteri, E., & Hofvind, S. (2019). Breast cancer mortality after implementation of organized population-based breast cancer screening in Norway. Journal of the National Cancer Institute, 112, 839–846.
doi: 10.1093/jnci/djz220
Dibden, A., Offman, J., Duffy, S. W., & Gabe, R. (2020). Worldwide review and meta-analysis of cohort studies measuring the effect of mammography screening programmes on incidence-based breast cancer mortality. Cancers (Basel), 12(4), 976.
doi: 10.3390/cancers12040976
Schmidt, M. E., Wiskemann, J., & Steindorf, K. (2018). Quality of life, problems, and needs of disease-free breast cancer survivors 5 years after diagnosis. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 27(8), 2077–2086.
doi: 10.1007/s11136-018-1866-8
World Health Organization. (2018). Health statistics and information systems. WHOQOL: Measuring quality of life. World Health Organization.
Health-Related Quality of Life (HRQOL). 2016. [updated May 27, 2016]. Retrieved March 14, 2018 from: https://www.cdc.gov/hrqol/
Agrawal, S. (2014). Late effects of cancer treatment in breast cancer survivors. South Asian Journal of Cancer, 3(2), 112–115.
doi: 10.4103/2278-330X.130445
Ye, M., Du, K., Zhou, J., Zhou, Q., Shou, M., Hu, B., et al. (2018). A meta-analysis of the efficacy of cognitive behavior therapy on quality of life and psychological health of breast cancer survivors and patients. Psycho-Oncology, 27, 1695.
doi: 10.1002/pon.4687
Sassi, F. (2006). Calculating QALYs, comparing QALY and DALY calculations. Health Policy and Planning., 21(5), 402–408.
doi: 10.1093/heapol/czl018
Research-based evaluation of the Norwegian Breast Cancer Screening Program. Final report. 2015.
Chuwa, E. W., Yeo, A. W., Koong, H. N., Wong, C. Y., Yong, W. S., Tan, P. H., et al. (2009). Early detection of breast cancer through population-based mammographic screening in Asian women: A comparison study between screen-detected and symptomatic breast cancers. The Breast Journal, 15(2), 133–139.
doi: 10.1111/j.1524-4741.2009.00687.x
Lindbohm, M. L., Kuosma, E., Taskila, T., Hietanen, P., Carlsen, K., Gudbergsson, S., et al. (2014). Early retirement and non-employment after breast cancer. Psycho-Oncology, 23(6), 634–641.
doi: 10.1002/pon.3459
Duncan, M., Moschopoulou, E., Herrington, E., Deane, J., Roylance, R., Jones, L., et al. (2017). Review of systematic reviews of non-pharmacological interventions to improve quality of life in cancer survivors. British Medical Journal Open, 7(11), e015860.
Groenendijk, R. P., Bult, P., Noppen, C. M., Boetes, C., Ruers, T. J., & Wobbes, T. (2003). Mitotic activity index in interval breast cancers. European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 29(1), 29–31.
doi: 10.1053/ejso.2002.1390
Hofvind, S., & Cancer in Norway,. (2016). Special Issue: The Norwegian Breast Cancer Screening Program, 1996–2016: Celebrating 20 years of organised mammographic screening (p. 2017). Cancer Registry of Norway.
Larsen, I. K., Smastuen, M., Johannesen, T. B., Langmark, F., Parkin, D. M., Bray, F., et al. (2009). Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. European Journal of Cancer (Oxford, England: 1990), 45(7), 1218–1231.
doi: 10.1016/j.ejca.2008.10.037
Act on the processing of personal data (Personal Data Act) [Lov om behandling av personopplysninger (personopplysningsloven)], (2018).
Brierley, J., & Gospodarowicz, M. K. (2017). TNM classification of malignant tumours (8th ed.). Wiley Blackwell.
EQ-5D-5L 2018. Retrieved from https://euroqol.org/eq-5d-instruments/eq-5d-5l-about/
EQ-5D-5L | Valuation | Crosswalk Index Value Calculator 2019. Retrieved October 24, 2019 from https://euroqol.org/eq-5d-instruments/eq-5d-5l-about/valuation-standard-value-sets/crosswalk-index-value-calculator/
van Hout, B., Janssen, M. F., Feng, Y. S., Kohlmann, T., Busschbach, J., Golicki, D., et al. (2012). Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 15(5), 708–715.
doi: 10.1016/j.jval.2012.02.008
Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 22(7), 1717–1727.
doi: 10.1007/s11136-012-0322-4
Jeffe, D. B., Pérez, M., Liu, Y., Collins, K. K., Aft, R. L., & Schootman, M. (2012). Quality of life over time in women diagnosed with ductal carcinoma in situ, early-stage invasive breast cancer, and age-matched controls. Breast Cancer Research and Treatment, 134(1), 379–391.
doi: 10.1007/s10549-012-2048-y
Koch, L., Jansen, L., Herrmann, A., Stegmaier, C., Holleczek, B., Singer, S., et al. (2013). Quality of life in long-term breast cancer survivors—A 10-year longitudinal population-based study. Acta Oncologica (Stockholm, Sweden)., 52(6), 1119–1128.
doi: 10.3109/0284186X.2013.774461
DiSipio, T., Hayes, S., Newman, B., & Janda, M. (2008). Health-related quality of life 18 months after breast cancer: Comparison with the general population of Queensland, Australia. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 16(10), 1141–1150.
doi: 10.1007/s00520-007-0392-y
de Haes, J. C., de Koning, H. J., van Oortmarssen, G. J., van Agt, H. M., de Bruyn, A. E., & van Der Maas, P. J. (1991). The impact of a breast cancer screening programme on quality-adjusted life-years. International Journal of Cancer, 49(4), 538–544.
doi: 10.1002/ijc.2910490411
Zahl, P. H., Kalager, M., Suhrke, P., & Nord, E. (2020). Quality-of-life effects of screening mammography in Norway. International Journal of Cancer, 146(8), 2104–2112.
doi: 10.1002/ijc.32539
Larsen, M., Moshina, N., Sagstad, S., & Hofvind, S. (2020). Factors associated with attendance and attendance patterns in a population-based mammographic screening program. Journal of Medical Screening, 28, 169–176.
doi: 10.1177/0969141320932945
Ganz, P. A., Rowland, J. H., Desmond, K., Meyerowitz, B. E., & Wyatt, G. E. (1998). Life after breast cancer: Understanding women’s health-related quality of life and sexual functioning. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 16(2), 501–514.
doi: 10.1200/JCO.1998.16.2.501
Goodwin, P. J., Ennis, M., Bordeleau, L. J., Pritchard, K. I., Trudeau, M. E., Koo, J., et al. (2004). Health-related quality of life and psychosocial status in breast cancer prognosis: Analysis of multiple variables. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 22(20), 4184–4192.
doi: 10.1200/JCO.2004.12.091
Vacek, P. M., Winstead-Fry, P., Secker-Walker, R. H., Hooper, G. J., & Plante, D. A. (2003). Factors influencing quality of life in breast cancer survivors. Quality of Life Research, 12(5), 527–537.
doi: 10.1023/A:1025098108717
Jones, M. P. (1996). Indicator and stratification methods for missing explanatory variables in multiple linear regression. Journal of the American Statistical Association., 91(433), 222–230.
doi: 10.1080/01621459.1996.10476680
More similar life expectancy for men and women. Statistics Norway; 2018.